Carduso Capital invests in PIMS-E, a Spin-off company of the University of Groningen that aims to develop an epinephrine dry powder inhaler as alternative to Epipen™.
Menu
Menu
Cyclops
- Convenient
- Reliable
- Easy-to-use
- Easy-to-carry
- Hygienic
- Less Cough
Carduso Capital invests in PIMS-E
Recent Posts
Categories
Categories
- Press release (7)
- Publication (1)
- Scientific publication (4)
- Status update (2)
Contact Us
Ceintuurbaan Noord 152
9301 NZ Roden
The Netherlands
T: +31 (0)50 – 2053 325
F: +31 (0)50 – 2053 326
E: info@pureims.com
Making Inhaling Easier
© 2021 pureims